Compound ID | 2756
Class: Beta-lactam
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Broad-spectrum activity with notable effect towards Pseudomonas aeruginosa |
| Description: | Semisynthetic antibiotic; derived from penicillin (ureidopenicillin); shows similar but inferior activity profile to carbenicillin |
| Institute where first reported: | Bristol-Myers Squibb Pharmaceutical |
| Year first mentioned: | 1968 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|